Mayo Clinic Labs @Work: Paul Schneider - Insights
As a national accounts executive for Mayo Clinic Laboratories, Paul Schneider helps to improve and advance diagnostic patient care by bringing Mayo Clinic Laboratories testing to many of the nation’s top health care systems.
The Evolution of Phlebotomy - Insights
PACE / State of FLHave you ever wondered how we came from bloodletting and leeches to present day phlebotomy? This presentation is going to walk you through the history and what has led us to some of the advancements in the field of...
Facebook Email or phone Password...
Facebook Email or phone Password...
Facebook Email or phone Password...
As part of Mayo Clinic’s Neuro-Oncology practice, the Division of Laboratory Genetics and Genomics tests about 50 brain tumors a week, and upwards of 1,500 brain tumors a year from all over the world.
New gene panel enhances brain tumor profiles - Insights
Cristiane (Cris) Ida, M.D., explains how Mayo Clinic Laboratories' updated neuro-oncology gene panel provides more clinically relevant information for managing adult and pediatric brain tumors.
Novel biomarkers added to movement disorders profile - Insights
Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' expanded movement disorders panel better identifies autoimmune conditions to guide appropriate treatment.
Identifying a precise genetic cause of hearing loss impacts clinical management. Nicole Boczek, Ph.D., and Melanie Meyer, M.S., CGC, explain how Mayo Clinic Laboratories' updated panel yields comprehensive results for optimal patient care.
Mayo Clinic Laboratories presents the 18th Bleeding and Thrombosing Diseases conference - Insights
This conference will provide reviews and updates about the laboratory and clinical aspects of bleeding and thrombosing disorders. Informational presentations will be supplemented with panel discussions and case presentations, followed by...